Nifty

:

20937.70

Sensex

:

69653.73

82.60 (0.40%)
357.59 (0.52%)

Login

Nifty
Sensex

:
:

20937.70
69653.73

82.60 (0.40%)
357.59 (0.52%)

Jubilant Pharmova Ltd.

Chemicals

Rating :

45/99

BSE: 530019 | NSE: JUBLPHARMA

Watchlist

NSE BSE

454.25

06-Dec-2023

Open
High
Low
Previous Close

461.10
461.95
452.45
458.70

Volume
Traded Value (lacs)
52 Week High
52 Week Low

175004
798.29
485.10
268.90

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

7,228.97
N/A
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

9,674.67
1.10%
1.34

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

0.80
-7.17
0.99

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-2.70
-14.90
-11.08

PAT CAGR (%)

10 Years
5 Years
3 Years

50.80
-19.51
-38.50

P:E (Median)

8 Years
5 Years
3 Years

14.75
13.89
13.54

P:BV (Average)

8 Years
5 Years
3 Years

2.07
1.63
1.50

EV:EBITDA (Average)

8 Years
5 Years
3 Years

8.71
7.86
8.46

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var%
Net Sales 186.30 222.90 -16.42% 217.40 204.60 6.26% 199.84 240.69 -16.97% 182.74 155.47 17.54%
Expenses 185.50 215.70 -14.00% 213.20 208.90 2.06% 197.66 220.39 -10.31% 184.63 173.29 6.54%
EBITDA 0.80 7.20 -88.89% 4.20 -4.30 - 2.18 20.30 -89.26% -1.89 -17.82 -
EBIDTM 0.43% 3.23% 1.93% -2.10% 1.09% 8.43% -1.03% -11.46%
Other Income 18.40 106.20 -82.67% 15.90 10.20 55.88% 13.66 7.21 89.46% 7.87 8.55 -7.95%
Interest 7.10 4.10 73.17% 6.40 3.20 100.00% 5.70 2.92 95.21% 5.53 2.74 101.82%
Depreciation 11.90 11.10 7.21% 11.40 9.20 23.91% 11.37 9.26 22.79% 11.59 9.23 25.57%
PBT 0.20 98.20 -99.80% 2.30 -6.50 - -1.23 15.33 - -11.14 -21.24 -
Tax 0.60 6.40 -90.62% 0.40 -1.30 - 29.63 4.87 508.42% -5.25 -5.64 -
PAT -0.40 91.80 - 1.90 -5.20 - -30.86 10.46 - -5.89 -15.60 -
PATM -0.21% 41.18% 0.87% -2.54% -15.44% 4.35% -3.22% -10.03%
EPS -0.03 5.76 - 0.12 -0.33 - -1.94 0.66 - -0.37 -0.98 -

Description Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var%
Net Sales 1,680.30 1,599.50 5.05% 1,586.90 1,451.70 9.31% 1,678.00 1,527.53 9.85% 1,552.51 1,310.53 18.46%
Expenses 1,438.50 1,380.80 4.18% 1,417.30 1,259.30 12.55% 1,458.78 1,280.18 13.95% 1,406.63 1,116.29 26.01%
EBITDA 241.80 218.70 10.56% 169.60 192.40 -11.85% 219.22 247.35 -11.37% 145.88 194.24 -24.90%
EBIDTM 14.39% 13.67% 10.69% 13.25% 13.06% 16.19% 9.40% 14.82%
Other Income 9.90 13.10 -24.43% 8.60 11.30 -23.89% 4.45 -2.96 - 9.47 5.91 60.24%
Interest 66.10 42.00 57.38% 61.90 39.90 55.14% 55.56 39.51 40.62% 50.69 36.62 38.42%
Depreciation 96.60 93.90 2.88% 89.70 94.60 -5.18% 271.23 100.55 169.75% 94.28 93.33 1.02%
PBT 89.00 39.10 127.62% 26.60 69.20 -61.56% -103.12 104.33 - 10.38 70.20 -85.21%
Tax 35.90 31.50 13.97% 19.20 22.30 -13.90% 14.10 46.58 -69.73% 24.77 19.43 27.48%
PAT 53.10 7.60 598.68% 7.40 46.90 -84.22% -117.22 57.75 - -14.39 50.77 -
PATM 3.16% 0.48% 0.47% 3.23% -6.99% 3.78% -0.93% 3.87%
EPS 3.96 0.34 1,064.71% 0.41 2.96 -86.15% -6.15 3.74 - -0.98 3.20 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 786.28 810.12 725.73 2,709.50 3,139.90 3,438.61 3,306.32 2,491.22 2,656.15 3,176.30 3,672.79 Net Sales Growth -4.54% 11.63% -73.22% -13.71% -8.69% 4.00% 32.72% -6.21% -16.38% -13.52% Cost Of Goods Sold 376.97 414.55 332.28 1,450.36 1,684.43 2,052.81 1,771.11 1,310.23 1,453.03 1,935.90 1,982.26 Gross Profit 409.31 395.56 393.45 1,259.14 1,455.48 1,385.80 1,535.21 1,180.99 1,203.13 1,240.41 1,690.53 GP Margin 52.06% 48.83% 54.21% 46.47% 46.35% 40.30% 46.43% 47.41% 45.30% 39.05% 46.03% Total Expenditure 780.99 806.89 719.27 2,282.44 2,769.00 3,117.74 2,767.08 2,173.21 2,343.86 2,893.94 3,083.89 Power & Fuel Cost - 75.37 62.31 280.40 369.20 358.28 339.80 268.18 298.40 328.83 360.17 % Of Sales - 9.30% 8.59% 10.35% 11.76% 10.42% 10.28% 10.77% 11.23% 10.35% 9.81% Employee Cost - 167.27 163.64 220.67 264.90 265.71 264.42 226.31 216.18 240.83 298.23 % Of Sales - 20.65% 22.55% 8.14% 8.44% 7.73% 8.00% 9.08% 8.14% 7.58% 8.12% Manufacturing Exp. - 49.59 40.23 218.14 271.29 258.31 228.40 206.97 214.72 243.68 257.18 % Of Sales - 6.12% 5.54% 8.05% 8.64% 7.51% 6.91% 8.31% 8.08% 7.67% 7.00% General & Admin Exp. - 80.49 93.87 44.02 71.77 77.63 73.39 68.32 57.32 72.55 104.14 % Of Sales - 9.94% 12.93% 1.62% 2.29% 2.26% 2.22% 2.74% 2.16% 2.28% 2.84% Selling & Distn. Exp. - 9.64 16.06 53.06 67.66 56.30 67.72 58.18 50.59 59.06 68.71 % Of Sales - 1.19% 2.21% 1.96% 2.15% 1.64% 2.05% 2.34% 1.90% 1.86% 1.87% Miscellaneous Exp. - 9.98 10.88 15.78 39.75 48.71 22.25 35.03 53.63 13.10 68.71 % Of Sales - 1.23% 1.50% 0.58% 1.27% 1.42% 0.67% 1.41% 2.02% 0.41% 0.36% EBITDA 5.29 3.23 6.46 427.06 370.90 320.87 539.24 318.01 312.29 282.36 588.90 EBITDA Margin 0.67% 0.40% 0.89% 15.76% 11.81% 9.33% 16.31% 12.77% 11.76% 8.89% 16.03% Other Income 55.83 137.89 126.16 47.88 173.23 78.00 46.21 51.90 61.74 106.42 29.88 Interest 24.73 18.52 10.99 101.80 136.20 128.96 135.17 174.25 200.66 233.29 284.80 Depreciation 46.26 43.25 36.91 99.97 107.40 86.48 82.59 81.13 86.98 107.41 175.29 PBT -9.87 79.34 84.72 273.17 300.54 183.43 367.69 114.52 86.39 48.08 158.71 Tax 25.38 29.46 4.23 58.69 -22.30 35.80 104.25 35.33 13.39 41.19 -68.98 Tax Rate -257.14% 37.13% 4.99% 21.48% -7.46% 19.52% 28.35% 30.85% 15.50% 16.72% 101.22% PAT -35.25 49.88 80.49 214.47 321.14 147.63 263.44 79.19 73.00 205.11 0.82 PAT before Minority Interest -35.25 49.88 80.49 214.47 321.14 147.63 263.44 79.19 73.00 205.11 0.82 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -4.48% 6.16% 11.09% 7.92% 10.23% 4.29% 7.97% 3.18% 2.75% 6.46% 0.02% PAT Growth -143.27% -38.03% -62.47% -33.22% 117.53% -43.96% 232.67% 8.48% -64.41% 24,913.41% EPS -2.21 3.13 5.05 13.46 20.16 9.27 16.54 4.97 4.58 12.88 0.05

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 6,497.71 6,281.73 6,130.16 6,098.53 9,154.41 9,110.82 7,517.84 5,861.43 5,749.13 5,826.25 5,803.36 Net Sales Growth 10.33% 2.47% 0.52% -33.38% 0.48% 21.19% 28.26% 1.95% -1.32% 0.39% Cost Of Goods Sold 2,085.24 1,877.94 1,488.01 1,536.01 3,140.58 3,521.84 2,862.51 2,002.74 2,116.20 2,663.02 2,438.46 Gross Profit 4,412.47 4,403.79 4,642.16 4,562.52 6,013.84 5,588.98 4,655.33 3,858.69 3,632.94 3,163.23 3,364.90 GP Margin 67.91% 70.10% 75.73% 74.81% 65.69% 61.34% 61.92% 65.83% 63.19% 54.29% 57.98% Total Expenditure 5,721.21 5,505.49 4,973.83 4,702.07 7,207.34 7,371.81 5,999.45 4,516.14 4,502.19 5,124.71 4,782.37 Power & Fuel Cost - 166.71 134.30 105.79 112.21 466.38 424.91 333.66 366.71 393.04 389.74 % Of Sales - 2.65% 2.19% 1.73% 1.23% 5.12% 5.65% 5.69% 6.38% 6.75% 6.72% Employee Cost - 2,166.02 2,043.39 1,922.88 2,127.68 1,925.96 1,555.88 1,230.93 1,125.09 1,090.28 1,105.17 % Of Sales - 34.48% 33.33% 31.53% 23.24% 21.14% 20.70% 21.00% 19.57% 18.71% 19.04% Manufacturing Exp. - 581.13 562.32 449.40 362.15 552.26 485.98 428.84 436.46 432.40 405.14 % Of Sales - 9.25% 9.17% 7.37% 3.96% 6.06% 6.46% 7.32% 7.59% 7.42% 6.98% General & Admin Exp. - 464.06 432.34 387.92 416.80 540.75 354.56 280.98 256.23 302.28 264.23 % Of Sales - 7.39% 7.05% 6.36% 4.55% 5.94% 4.72% 4.79% 4.46% 5.19% 4.55% Selling & Distn. Exp. - 161.60 209.71 177.15 194.71 267.70 247.85 185.79 135.54 203.98 160.04 % Of Sales - 2.57% 3.42% 2.90% 2.13% 2.94% 3.30% 3.17% 2.36% 3.50% 2.76% Miscellaneous Exp. - 88.03 103.77 122.93 853.22 96.92 67.76 53.20 65.96 39.72 160.04 % Of Sales - 1.40% 1.69% 2.02% 9.32% 1.06% 0.90% 0.91% 1.15% 0.68% 0.34% EBITDA 776.50 776.24 1,156.33 1,396.46 1,947.07 1,739.01 1,518.39 1,345.29 1,246.94 701.54 1,020.99 EBITDA Margin 11.95% 12.36% 18.86% 22.90% 21.27% 19.09% 20.20% 22.95% 21.69% 12.04% 17.59% Other Income 32.42 38.33 11.29 17.64 47.43 35.74 40.03 24.86 13.37 42.45 19.06 Interest 234.25 188.20 145.49 184.10 287.41 219.81 284.28 341.11 371.35 367.61 337.11 Depreciation 551.81 554.03 381.70 348.95 461.93 370.90 415.05 291.40 346.74 287.95 281.17 PBT 22.86 72.34 640.43 881.05 1,245.17 1,184.04 859.08 737.64 542.22 88.43 421.78 Tax 93.97 92.66 217.43 297.22 312.29 326.80 224.66 163.02 155.40 80.48 69.64 Tax Rate 411.07% 597.04% 33.95% 34.57% 25.80% 36.16% 26.15% 22.10% 28.66% 199.55% 33.60% PAT -71.11 -60.98 413.94 562.87 898.24 574.46 642.81 575.66 391.83 -57.76 109.04 PAT before Minority Interest -67.27 -64.88 413.02 562.61 898.24 577.01 634.42 574.63 386.82 -40.16 137.64 Minority Interest 3.84 3.90 0.92 0.26 0.00 -2.55 8.39 1.03 5.01 -17.60 -28.60 PAT Margin -1.09% -0.97% 6.75% 9.23% 9.81% 6.31% 8.55% 9.82% 6.82% -0.99% 1.88% PAT Growth -143.62% - -26.46% -37.34% 56.36% -10.63% 11.66% 46.92% - - EPS -4.46 -3.83 25.98 35.33 56.39 36.06 40.35 36.14 24.60 -3.63 6.84

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 2,414.55 2,439.07 1,282.44 2,607.30 2,340.31 2,249.38 2,042.81 2,013.73 1,944.96 1,732.75 Share Capital 15.93 15.93 15.93 15.93 15.93 15.93 15.93 15.93 15.93 15.45 Total Reserves 2,394.77 2,422.64 1,266.52 2,591.36 2,324.33 2,233.29 2,026.39 1,997.80 1,929.04 1,717.31 Non-Current Liabilities 215.70 168.90 442.00 1,450.86 1,225.58 1,136.68 1,428.31 1,136.80 1,988.09 1,535.29 Secured Loans 95.00 95.00 95.00 728.92 802.83 725.14 1,047.78 1,093.32 1,636.18 1,039.46 Unsecured Loans 79.00 79.00 325.00 598.99 336.74 334.24 339.24 21.51 102.89 101.59 Long Term Provisions 22.82 23.41 5.34 66.84 61.95 57.37 50.69 45.44 97.05 210.41 Current Liabilities 361.19 252.26 120.15 1,375.23 1,297.73 1,238.48 910.67 1,155.23 1,307.78 3,382.48 Trade Payables 164.27 158.54 15.90 618.58 596.05 749.18 486.91 364.49 507.57 599.25 Other Current Liabilities 58.24 82.65 19.95 104.65 214.28 270.24 224.33 316.73 388.02 1,468.25 Short Term Borrowings 127.50 0.00 73.00 622.97 462.71 190.64 177.07 453.94 340.43 1,097.13 Short Term Provisions 11.18 11.07 11.30 29.02 24.70 28.42 22.36 20.07 71.75 217.86 Total Liabilities 2,991.44 2,860.23 1,844.59 5,433.39 4,863.62 4,624.54 4,381.79 4,305.76 5,240.83 6,650.52 Net Block 687.40 636.51 127.08 1,864.72 1,491.35 1,437.81 1,421.15 1,415.24 1,445.93 2,151.14 Gross Block 956.04 866.98 148.94 2,288.40 1,822.01 1,684.84 1,587.18 1,501.57 2,302.83 3,243.34 Accumulated Depreciation 268.64 230.46 21.86 423.68 330.66 247.03 166.03 86.33 856.90 1,092.20 Non Current Assets 2,412.56 2,334.41 1,778.35 3,711.26 3,582.46 3,298.65 3,237.48 3,238.16 3,586.53 4,701.50 Capital Work in Progress 46.97 35.26 0.33 59.09 283.82 115.32 65.40 35.68 20.02 241.94 Non Current Investment 1,656.57 1,645.75 1,645.98 1,764.03 1,763.89 1,706.30 1,699.94 1,701.90 1,766.26 2,005.69 Long Term Loans & Adv. 18.59 13.98 4.96 16.03 18.02 12.27 21.80 55.41 310.60 267.34 Other Non Current Assets 3.04 2.92 0.00 7.39 25.38 26.95 29.19 29.92 43.72 35.39 Current Assets 578.88 525.81 66.25 1,722.13 1,281.17 1,325.89 1,144.31 1,067.60 1,654.31 1,949.02 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 9.70 7.35 0.00 0.38 Inventories 313.60 323.18 0.00 656.38 491.94 585.58 454.43 475.26 515.86 733.52 Sundry Debtors 188.52 130.70 0.00 425.45 480.52 493.66 385.67 341.30 318.76 529.60 Cash & Bank 10.99 22.52 40.33 257.73 34.74 37.51 76.66 41.05 136.74 178.71 Other Current Assets 65.76 21.69 25.92 354.20 273.96 209.14 217.86 202.64 682.95 506.82 Short Term Loans & Adv. 43.19 27.71 0.00 28.37 23.83 44.78 32.90 13.42 647.53 446.31 Net Current Assets 217.69 273.55 -53.91 346.90 -16.57 87.41 233.63 -87.63 346.53 -1,433.46 Total Assets 2,991.44 2,860.22 1,844.60 5,433.39 4,863.63 4,624.54 4,381.79 4,305.76 5,240.84 6,650.52

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 5,399.28 5,318.56 4,741.49 5,603.88 4,808.92 4,086.53 3,436.04 2,966.26 2,453.52 2,626.51 Share Capital 15.91 15.92 15.92 15.93 15.93 15.58 15.57 15.54 15.93 15.45 Total Reserves 5,377.18 5,298.98 4,724.75 5,587.95 4,792.94 4,070.78 3,419.98 2,950.72 2,437.59 2,611.07 Non-Current Liabilities 3,765.02 2,921.59 2,973.05 4,087.52 4,420.21 3,417.47 3,826.06 3,347.13 4,036.15 2,184.95 Secured Loans 265.05 200.94 20.78 728.92 811.65 729.88 1,581.96 2,620.41 3,316.29 1,716.67 Unsecured Loans 2,845.32 2,263.30 2,543.19 3,010.76 3,431.24 2,317.93 1,923.07 392.79 375.00 0.22 Long Term Provisions 92.25 95.67 94.01 150.75 114.35 107.08 80.69 70.31 67.04 219.53 Current Liabilities 1,772.40 1,591.60 1,048.83 2,619.01 2,089.73 2,004.69 1,684.04 2,464.44 2,129.16 3,894.41 Trade Payables 821.32 567.74 520.48 1,090.27 1,020.13 1,136.16 749.49 612.12 721.19 718.14 Other Current Liabilities 552.10 838.52 371.73 674.21 473.57 505.87 572.70 951.43 793.31 1,731.20 Short Term Borrowings 258.25 64.00 20.00 649.89 499.71 244.85 255.60 748.97 517.17 1,187.83 Short Term Provisions 140.73 121.34 136.62 204.64 96.31 117.81 106.24 151.93 97.49 257.25 Total Liabilities 10,929.21 9,829.59 8,763.40 12,310.41 11,318.96 9,457.17 8,898.75 8,739.70 8,618.83 8,863.81 Net Block 5,183.26 4,870.61 4,608.75 6,339.97 5,648.38 5,400.55 5,106.73 5,104.42 4,911.33 5,098.78 Gross Block 7,431.77 6,758.89 6,089.57 7,982.83 6,905.50 6,288.86 5,672.38 5,390.82 7,362.10 7,330.63 Accumulated Depreciation 2,248.51 1,888.28 1,480.83 1,642.85 1,257.12 888.31 565.66 286.40 2,450.76 2,231.85 Non Current Assets 7,166.81 6,320.40 5,810.90 7,272.06 6,734.16 6,267.41 5,950.63 5,864.37 5,904.29 5,935.78 Capital Work in Progress 1,561.48 1,089.57 896.99 768.39 901.43 670.97 683.78 611.32 596.60 472.39 Non Current Investment 256.42 238.60 240.96 69.36 115.11 123.52 102.71 85.43 39.50 33.99 Long Term Loans & Adv. 161.55 117.64 62.84 86.81 68.59 71.79 56.32 62.67 327.17 328.42 Other Non Current Assets 4.09 3.98 1.35 7.53 0.66 0.58 1.08 0.53 29.68 2.21 Current Assets 3,762.40 3,509.19 2,952.50 5,038.35 4,584.80 3,189.76 2,948.12 2,875.32 2,714.54 2,928.03 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 1,380.53 1,254.87 1,129.38 1,845.38 1,417.39 1,391.39 1,220.40 1,203.10 1,235.33 1,341.42 Sundry Debtors 961.24 927.99 819.90 1,293.22 1,271.55 1,130.76 1,005.30 950.50 819.27 805.87 Cash & Bank 1,014.30 984.24 671.32 1,399.87 1,370.41 248.79 459.63 344.58 394.34 479.53 Other Current Assets 406.33 110.93 242.37 419.59 525.44 418.81 262.79 377.13 265.59 301.21 Short Term Loans & Adv. 271.28 231.17 89.53 80.29 39.80 45.75 37.06 133.06 144.56 136.04 Net Current Assets 1,990.00 1,917.59 1,903.67 2,419.34 2,495.07 1,185.06 1,264.08 410.88 585.38 -966.38 Total Assets 10,929.21 9,829.59 8,763.40 12,310.41 11,318.96 9,457.17 8,898.75 8,739.69 8,618.83 8,863.81

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity -65.11 -3.55 608.38 316.76 181.74 557.85 419.15 164.30 285.55 548.68 PBT 79.34 84.72 273.17 298.84 183.43 367.69 114.52 86.39 246.30 -68.16 Adjustment -35.19 -48.68 196.45 103.01 159.26 206.69 230.45 259.62 59.49 606.08 Changes in Working Capital -91.82 -3.42 181.36 -65.06 -112.03 41.63 79.56 -168.06 17.57 11.79 Cash after chg. in Working capital -47.67 32.62 650.98 336.79 230.66 616.02 424.53 177.94 323.36 549.72 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -17.45 -19.38 -42.60 -20.03 -48.92 -58.17 -5.38 -13.65 -37.81 -1.04 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 -16.79 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 31.07 93.10 177.96 -197.71 -284.79 -126.93 -43.06 521.70 1,319.35 -193.78 Net Fixed Assets -100.77 -752.97 2,198.22 -241.66 -305.67 -147.58 -115.33 785.60 1,162.43 -166.96 Net Investments -10.82 0.23 118.05 -0.14 -57.59 3.34 -0.39 57.01 239.81 -27.56 Others 142.66 845.84 -2,138.31 44.09 78.47 17.31 72.66 -320.91 -82.89 0.74 Cash from Financing Activity 22.51 -107.37 -781.64 -41.05 85.28 -470.44 -338.40 -784.44 -1,646.65 -360.79 Net Cash Inflow / Outflow -11.53 -17.82 4.69 78.00 -17.77 -39.52 37.69 -98.44 -41.75 -5.90 Opening Cash & Equivalents 22.52 40.35 96.70 18.70 36.47 75.99 38.29 136.74 178.49 184.38 Closing Cash & Equivalent 10.99 22.52 40.33 96.70 18.70 36.47 75.99 38.29 136.74 178.49

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 660.67 837.54 1,784.27 1,542.94 1,121.51 1,303.20 1,268.49 1,098.89 783.26 772.27 PBT 27.78 630.45 1,212.01 1,210.53 903.81 859.08 737.64 542.22 40.32 207.28 Adjustment 782.88 579.47 716.48 760.74 861.53 687.81 637.90 737.89 725.84 756.60 Changes in Working Capital 54.31 -178.29 249.90 -179.67 -300.53 14.15 36.88 -133.16 96.40 -110.70 Cash after chg. in Working capital 864.97 1,031.63 2,178.39 1,791.60 1,464.82 1,561.04 1,412.42 1,146.96 862.57 853.18 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -204.30 -194.09 -394.12 -248.66 -343.31 -257.84 -143.94 -48.07 -79.31 -80.91 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -544.41 -380.37 -739.01 -327.00 -1,011.84 -617.70 -450.39 -312.53 -343.33 -174.42 Net Fixed Assets -100.77 -752.97 2,198.22 -241.66 -305.67 -147.58 -115.33 785.60 1,162.43 -166.96 Net Investments -10.82 0.23 118.05 -0.14 -57.59 3.34 -0.39 57.01 239.81 -27.56 Others -432.82 372.37 -3,055.28 -85.20 -648.58 -473.46 -334.67 -1,155.14 -1,745.57 20.10 Cash from Financing Activity -156.68 -32.60 -1,709.39 -1,050.37 657.43 -901.13 -685.87 -842.75 -502.69 -414.41 Net Cash Inflow / Outflow -40.43 424.57 -664.13 165.56 767.10 -215.63 132.22 -56.38 -62.76 183.44 Opening Cash & Equivalents 983.82 501.96 1,230.81 1,005.40 244.18 456.44 339.27 391.64 473.49 279.65 Closing Cash & Equivalent 1,013.92 983.82 501.96 1,230.81 1,005.40 244.18 456.44 339.27 391.63 473.49

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 151.35 153.10 80.52 163.69 146.93 141.21 128.22 126.43 122.11 112.20 ROA 1.70% 3.42% 5.89% 6.24% 3.11% 5.85% 1.82% 1.53% 3.45% 0.01% ROE 2.06% 4.33% 11.03% 12.98% 6.43% 12.28% 3.90% 3.69% 11.15% 0.05% ROCE 3.67% 4.36% 11.82% 10.10% 8.10% 13.57% 7.64% 7.13% 10.35% 4.27% Fixed Asset Turnover 0.89 1.43 2.22 1.53 1.96 2.04 1.70 1.47 1.20 1.20 Receivable days 71.91 65.74 0.00 52.66 51.70 48.00 50.58 43.16 46.50 44.21 Inventory Days 143.45 162.54 0.00 66.74 57.19 56.78 64.69 64.81 68.48 64.48 Payable days 142.11 95.81 79.84 78.11 80.49 81.70 70.96 68.13 68.44 64.82 Cash Conversion Cycle 73.25 132.47 -79.84 41.29 28.41 23.08 44.31 39.84 46.55 43.87 Total Debt/Equity 0.13 0.07 0.38 0.75 0.73 0.63 0.83 0.90 1.17 1.91 Interest Cover 5.28 8.71 3.68 3.19 2.42 3.72 1.66 1.43 2.06 0.76

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 339.04 333.91 297.84 351.83 301.93 262.33 220.61 190.90 154.04 170.07 ROA -0.63% 4.44% 5.34% 7.60% 5.55% 6.91% 6.52% 4.46% -0.46% 1.60% ROE -1.21% 8.21% 10.88% 17.25% 12.97% 16.87% 17.95% 14.27% -1.58% 5.39% ROCE 2.53% 9.97% 11.89% 15.07% 13.06% 15.21% 14.44% 12.42% 5.72% 7.92% Fixed Asset Turnover 0.89 0.95 0.87 1.23 1.38 1.26 1.09 0.92 0.81 0.84 Receivable days 54.89 52.04 63.24 51.13 48.12 51.58 59.43 54.81 49.56 46.53 Inventory Days 76.57 70.98 89.02 65.05 56.26 63.07 73.64 75.51 78.58 75.51 Payable days 134.99 133.47 191.38 58.75 55.42 56.86 54.84 53.44 52.17 51.42 Cash Conversion Cycle -3.54 -10.45 -39.12 57.43 48.96 57.79 78.23 76.88 75.98 70.61 Total Debt/Equity 0.63 0.55 0.55 0.83 1.01 0.85 1.18 1.51 1.95 1.67 Interest Cover 1.15 5.33 5.67 5.21 5.11 4.02 3.16 2.46 1.11 1.61

Top Investors:

rekha rakesh jhunjhunwala

east bridge capital master fund limited

government pension fund global

east bridge capital master fund i ltd

investor eduction and protection fund authority ministry of corporate affairs

abakkus emerging opportunities fund-1

Annual Reports:

News Update:

Jubilant Pharmova’s arm receives USFDA’s approval for Technetium Sulfur Colloid Injection
11th Nov 2023, 10:32 AM

For this approval, Jubilant is eligible for 180 days of exclusivity through the ‘Competitive Generic Therapy’ designation from the USFDA
Read More
Jubilant Pharmova - Quarterly Results
27th Oct 2023, 14:28 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback